Hello and welcome back to Equity a Tech Crunch podcast about the business of

startups where we unpack the numbers and the nuance behind the headlines. I'm

Marianne Asavado and this is our interview show where we sit down with a

guest think about their work and

unpack the rest. Today we're bringing you a special mini episode led by

Tech Crunch's very own Morgan sung. During last year's disrupt Morgan caught up

with Shruti Duavetti the co-founder and CEO of Health Tech

Startup Dooley.

Dooley, which is focused on simplifying and personalizing contraception for young women in India

and beyond, was part of this year's startup Battlefield 200.

The pair talked about the stigma around contraception,

cultural roadblocks duly faces that its US and UK counterparts may not have to consider,

and of course what's next for the startup. Enjoy. So do you want to

introduce yourself? Yeah so my name is Shrudy I'm the founder and CEO of

Dooley.

Dooley is a digital health platform that's simplifying and personalizing contraception

for young women in India and beyond.

So yeah, that's kind of what I do.

And we've seen a lot of women's health care and reproductive health care,

startups in the market, you know, fundraising.

But at the same time, there's still a real lack of them in this space.

What is the reception like downstairs to Dooley and to I guess the idea of like

...